Bluejay Investor Presentation Deck

Financial Highlights Financial Info (September 30, 2023) Cash Est. Cash Runway Clean Balance Sheet BJDX (NASDAQ) (November 28, 2023) Market Cap Average Daily Trading Volume (3 months) Shares Outstanding Closing Price ●●● DIAGNOSTICS $5.1 M < 12 months No outstanding warrants or debt $3.85M 670K shares 1.2M $3.11 The SymphonyTM System and SymphonyTM Cartridge have not been cleared or approved by the U.S. FDA Symphony Symphony The Co HORSGATENALLINE ON Fel Symphony Symphony bluejay Sympheny Pu Kelanta Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | November 2023 18

View entire presentation